Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Langer

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Hamostaseologie|April 21, 2026
Florian Langer
Hamostaseologie|June 22, 2026
Florian Langer
Trends in Cardiovascular Medicine|February 26, 2022
Editorial commentary: A one-fits-all approach to cancer-associated thrombosis - Are we there yet?Florian Langer
European Heart Journal|May 9, 2025
From small Dutch cohort studies to large-scale nationwide data: impact of COVID-19 on the risk of pulmonary embolismFlorian Langer
Hamostaseologie|May 17, 2017
Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism. What do we know so far?Minna Voigtlaender, Florian Langer
Hamostaseologie|March 28, 2018
Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolismMinna Voigtlaender, Florian Langer
Innere Medizin (Heidelberg, Germany)|August 25, 2025
[Extended secondary prevention in cancer-associated venous thromboembolism: API-CAT establishes clarity]Florian Langer, Sirka Nitschmann
VASA. Zeitschrift Fur Gefasskrankheiten|January 13, 2018
Management of cancer-associated venous thromboembolism - a case-based practical approachMinna Voigtlaender, Florian Langer
Hamostaseologie|May 2, 2020
Factors Influencing the Choice between DOACs and LMWHs: A Survey of German Physicians on the Treatment of Cancer-Associated Venous ThromboembolismAxel Matzdorff, Florian Langer
Hamostaseologie|December 21, 2021
Management of Vascular Thrombosis in Patients with ThrombocytopeniaMinna Voigtlaender, Florian Langer
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Hamostaseologie|April 21, 2026
Florian Langer
Hamostaseologie|June 22, 2026
Florian Langer
Trends in Cardiovascular Medicine|February 26, 2022
Editorial commentary: A one-fits-all approach to cancer-associated thrombosis - Are we there yet?Florian Langer
European Heart Journal|May 9, 2025
From small Dutch cohort studies to large-scale nationwide data: impact of COVID-19 on the risk of pulmonary embolismFlorian Langer
Hamostaseologie|May 17, 2017
Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism. What do we know so far?Minna Voigtlaender, Florian Langer
Hamostaseologie|March 28, 2018
Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolismMinna Voigtlaender, Florian Langer
Innere Medizin (Heidelberg, Germany)|August 25, 2025
[Extended secondary prevention in cancer-associated venous thromboembolism: API-CAT establishes clarity]Florian Langer, Sirka Nitschmann
VASA. Zeitschrift Fur Gefasskrankheiten|January 13, 2018
Management of cancer-associated venous thromboembolism - a case-based practical approachMinna Voigtlaender, Florian Langer
Hamostaseologie|May 2, 2020
Factors Influencing the Choice between DOACs and LMWHs: A Survey of German Physicians on the Treatment of Cancer-Associated Venous ThromboembolismAxel Matzdorff, Florian Langer
Hamostaseologie|December 21, 2021
Management of Vascular Thrombosis in Patients with ThrombocytopeniaMinna Voigtlaender, Florian Langer
Pageof 13